Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Lemaitre Vascular (LMAT) Shares Outstanding (Diluted Average) (2016 - 2025)

Lemaitre Vascular (LMAT) has disclosed Shares Outstanding (Diluted Average) for 15 consecutive years, with $22.9 million as the latest value for Q2 2025.

  • Quarterly Shares Outstanding (Diluted Average) rose 1.05% to $22.9 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $22.9 million through Jun 2025, up 1.05% year-over-year, with the annual reading at $22.8 million for FY2024, 1.59% up from the prior year.
  • Shares Outstanding (Diluted Average) for Q2 2025 was $22.9 million at Lemaitre Vascular, roughly flat from $22.9 million in the prior quarter.
  • The five-year high for Shares Outstanding (Diluted Average) was $22.9 million in Q1 2025, with the low at $168000.0 in Q1 2022.
  • Average Shares Outstanding (Diluted Average) over 5 years is $16.1 million, with a median of $22.1 million recorded in 2022.
  • The sharpest move saw Shares Outstanding (Diluted Average) plummeted 99.19% in 2022, then surged 13158.33% in 2023.
  • Over 5 years, Shares Outstanding (Diluted Average) stood at $21.5 million in 2021, then increased by 3.24% to $22.2 million in 2022, then rose by 1.14% to $22.4 million in 2023, then grew by 1.59% to $22.8 million in 2024, then increased by 0.51% to $22.9 million in 2025.
  • According to Business Quant data, Shares Outstanding (Diluted Average) over the past three periods came in at $22.9 million, $22.9 million, and $22.8 million for Q2 2025, Q1 2025, and Q4 2024 respectively.